Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-729-0 | CAS number: 95009-01-1
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jan 20, 2016 - Dec 07, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- OECD 406:1992
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The guinea pig maximization test (GPMT) is already available for the registration outside of EU. Therefore, LLNA is not conducted.
Test material
- Reference substance name:
- Sodium [4-[[dihydroxy[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzenesulphonato(3-)]cuprate(1-)
- EC Number:
- 305-729-0
- EC Name:
- Sodium [4-[[dihydroxy[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzenesulphonato(3-)]cuprate(1-)
- Cas Number:
- 95009-01-1
- Molecular formula:
- C18H9CuN6O10S.Na
- IUPAC Name:
- Reaction products of diazotized 4-aminobenzenesulfonic acid coupled with resorcinol subsequently coupled with diazotised 2-amino-4,6-dinitrophenol, copper (2+) complexes, sodium salts
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): Everlan SL65
- Substance type: Powder
- Composition of test material, percentage of components: 71.19%
- Lot/batch No.: 3010
- Storage condition of test material: Ambient
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- - Source: WEI XIN HANG
- Weight at study initiation: 332.5-449.5g
- Housing: Every five animals were housed in a stainless steel wire mesh cage
- Acclimation period: 7 days
- Temperature (°C): 21 ± 2 °C
- Humidity (%): 55 ± 15%
- Photoperiod: 12-hrs dark / 12-hrs light
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- 0.1mlLand 0.5mL 4% of Everlan SL65 for intradermal and epicutaneous, respectively
- Day(s)/duration:
- Day1 and Day7 for intradermal and epicutaneous, respectively
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 0.5 mL 4% of Everlan SL65
- Day(s)/duration:
- Day23
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- For control group: five
For test group: ten - Positive control substance(s):
- yes
- Remarks:
- α-Hexylcinnamaldehyde (HCA)
Results and discussion
- Positive control results:
- The latest results showed that positive control animals had shown skin reactions of 1-2 and the sensitization rate of α-Hexylcinnamaldehyde (HCA) was 100%.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 4%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 4%
- No. with + reactions:
- 5
- Total no. in group:
- 5
Any other information on results incl. tables
Table 1. The body weight of the guinea pigs
Group |
Sex |
Animal ID. |
Animal Weight (g) |
Weight Change (g) |
|
Day 1 |
Day 26 |
||||
Control group |
Male |
11 |
417.9 |
506.4 |
+ 88.5 |
12 |
449.5 |
538.8 |
+ 89.3 |
||
13 |
389.3 |
492.8 |
+ 103.5 |
||
14 |
332.5 |
433.2 |
+ 100.7 |
||
15 |
448.6 |
545.2 |
+ 96.6 |
||
Test group |
Male |
16 |
406.8 |
504.0 |
+ 97.2 |
17 |
428.6 |
517.8 |
+ 89.2 |
||
18 |
426.8 |
515.6 |
+ 88.8 |
||
19 |
346.9 |
444.2 |
+ 97.3 |
||
20 |
389.6 |
475.2 |
+ 85.6 |
||
21 |
395.6 |
488.6 |
+ 93.0 |
||
22 |
368.5 |
458.6 |
+ 90.1 |
||
23 |
428.6 |
512.0 |
+ 83.4 |
||
24 |
435.4 |
520.0 |
+ 84.6 |
||
25 |
348.9 |
436.4 |
+ 87.5 |
||
Table 2. Individual skin reaction of guinea pigs
Group |
Sex |
Animal ID. |
Grade of skin reaction1 |
Percent of Animals Sensitized |
Sensitizing Capacity2 |
|
24 ± 1 hrs |
48 ± 1 hrs |
|||||
Control group |
Male |
11 |
0 |
0 |
0% |
Weak |
12 |
0 |
0 |
||||
13 |
0 |
0 |
||||
14 |
0 |
0 |
||||
15 |
0 |
0 |
||||
Test group |
Male |
16 |
0 |
0 |
0% |
Weak |
17 |
0 |
0 |
||||
18 |
0 |
0 |
||||
19 |
0 |
0 |
||||
20 |
0 |
0 |
||||
21 |
0 |
0 |
||||
22 |
0 |
0 |
||||
23 |
0 |
0 |
||||
24 |
0 |
0 |
||||
25 |
0 |
0 |
||||
1 The skin reaction was grading according to “Magnusson and Kligman scale”.
2 The sensitizing capacity of the test article was classified according to the “Scoring system of Kligman”.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to OECD 406 test method and “Scoring system of Kligman”, the sensitization rate of Everlan SL65 was 0% and Everlan SL65 caused no notable sensitisation potential in guinea pigs. Therefore, Everlan SL65 did not meet a category for classification based on GHS criteria.
- Executive summary:
This test using the procedures outlined in the SuperLab Study Plan for M62-151100103002EN which is based on the SOP for the OECD 406 (SOPP-339) and OECD 406 (OECD, 1992). The results of this OECD 406 test for Everlan SL65 show that test reliability criteria was met.
A 4% Everlan SL65 was used for intradermal injection and occlusively patched to ten test guinea pigs to induce sensitization.The normal saline was used for similar injection and occlusively patched to five control guinea pigs. Following a recovery period, animals received a challenge patch with 4% Everlan SL65. The skin sensitization reactions were scored at approximately 24 and 48 hours after patch removal. At the end of study, body weight increase was observed in all animals. During 48 hours after challenge exposure, 0% treated animals showed sensitization to the Everlan SL65. Under the conditions of this study, Everlan SL65 did not caused any sensitization in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
